Aurinia Pharmaceuticals (AUPH) Retained Earnings (2016 - 2026)
Aurinia Pharmaceuticals (AUPH) reported Retained Earnings of -$880000.0 for Q1 2026, up 99.9% on a YoY basis from -$440212.1 in Q1 2025, and down 46.91% quarter-over-quarter from -$599000.0 in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Retained Earnings (2016 - 2026) Analysis & Trends
Aurinia Pharmaceuticals has reported Retained Earnings for 11 years, with the latest figure at -$880000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 99.9% year-over-year to -$880000.0; the trailing twelve-month figure through Mar 2026 stood at -$880000.0 (up 99.9% YoY), and the FY2025 full-year result was -$599000.0, up 99.94% from the prior year.
- Retained Earnings for Q1 2026 stood at -$880000.0, down from -$599000.0 in the prior quarter.
- The five-year high for Retained Earnings was -$599000.0 in Q4 2025, with the low at -$942.3 million in Q4 2023.
- Historically, Retained Earnings has averaged -$317.6 million across 5 years, with a median of -$1.0 million in 2023.
- The largest YoY upside for Retained Earnings was 99.94% in 2025 against a maximum downside of 106835.13% in 2025.
- Aurinia Pharmaceuticals' Retained Earnings stood at -$864.3 million in 2022, then retreated by 9.03% to -$942.3 million in 2023, then rose by 0.61% to -$936.6 million in 2024, then jumped by 99.94% to -$599000.0 in 2025, then slumped by 46.91% to -$880000.0 in 2026.
- The last three Retained Earnings figures came in at -$880000.0 (Q1 2026), -$599000.0 (Q4 2025), and -$749000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Aurinia Pharmaceuticals | 2.18 Bn | 1.80 Bn | 71.20 Mn | -880,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -880,000.00 |
| Dec 31, 2025 | -599,000.00 |
| Sep 30, 2025 | -749,000.00 |
| Jun 30, 2025 | -905,000.00 |
| Mar 31, 2025 | -913.23 Mn |
| Dec 31, 2024 | -936.57 Mn |
| Sep 30, 2024 | -938.00 Mn |
| Jun 30, 2024 | -859,000.00 |
| Mar 31, 2024 | -854,000.00 |
| Dec 31, 2023 | -942.32 Mn |
| Sep 30, 2023 | -947,000.00 |
| Jun 30, 2023 | -1.02 Mn |
| Mar 31, 2023 | -988,000.00 |
| Dec 31, 2022 | -864.30 Mn |
| Sep 30, 2022 | -1.53 Mn |
| Jun 30, 2022 | -1.85 Mn |
| Mar 31, 2022 | -793.75 Mn |
| Dec 31, 2021 | -852,000.00 |
| Sep 30, 2021 | -794,000.00 |
| Jun 30, 2021 | -672.55 Mn |